Skip To Main Content
Chun An Chen on Muck Rack

Chun An Chen

As seen in: MDPI, International Journal of Sexual Health, Cell Reports Medicine, Canadian Journal of Infectious Diseases & Medical Microbiology, CCSE, Pakistan Journal of Medical Sciences, Bioprocess Online, Emirates Journal of Food and Agriculture, Outsourced Pharma, EJSO - European Journal of Surgical Oncology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chun An

Contact Chun An, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pretreatment Thymic Computed Tomography Density Predicts Pathological Response and Survival after Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma

|
By Zhenyuan Yang, Yizhou Huang, Hongmu Li, Maohui Chen, Taidui Zeng, Shuliang Zhang, Chun An Chen, Bin Zheng
| EJSO - European Journal of Surgical Oncology Verified
Keywords esophageal squamous cell carcinoma thymic density neoadjuvant immunochemotherapy pathological response survival Get full text access Log in, subscribe or purchase for full access. Reference 1. Sun, J.M. ∙ Shen, L. ∙ Shah, M.A. ... Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study Lancet. 2021; 398:759-771 2. Kato, K. ∙ Kojima, T. ∙ Hara, H. ...
Open in Who Shared Issue with article?

FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia

|
By Yao Guo, Zhiyong Peng, Yan Xiao, Zhiguang Chang, Yuming Zhao, Qi Zhang, Lingling Ma, Shuping Li, Chi-Kong Li, Kam Tong Leung, Zhizhuang Joe Zhao, Chun An Chen, Yun Chen, Dengyang Zhang, Liuting Yu
| Cell Reports Medicine Verified
Keywords AML FLT3 FLT3L ligand-drug conjugate cell cycle DM1 chemotherapy resistance Introduction Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy driven by multiple genetic mutations.1 Current first-line treatments for AML include cytarabine, daunorubicin, and idarubicin.2 However, the non-selective nature of cytotoxic chemotherapy results in substantial adverse effects and frequent relapse, with a 5-year survival rate of only 30%–35%.2 To improve selectivity,...
Open in Who Shared Issue with article?

05.10.25 -- Bioprocess Online Best Of April

|
By Chun An Chen, Nero Haralalka, William Boomershine, Karim Abdelkader
| Bioprocess Online Verified
APRIL'S BEST FEATURED EDITORIAL 3 Strategies For mAb Manufacturing: How Do You Choose? As cost and supply come under more scrutiny, there are primarily three scaling strategies for mAb manufacturing that can be leveraged, each with its own set of pros and cons.
Open in Who Shared Issue with article?
See all 6 licensed articles (18 Total)